idarubicin has been researched along with Primary Myelofibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iland, HJ; Mohamed, M; Sharma, S; Supple, SG | 1 |
| Batlle, M; Feliu, E; Fernández-Avilés, F; Gómez Espuch, J; Granada, I; Millá, F; Navarro, JT; Ribera, JM | 1 |
| Boaziz, C; Caillou, B; Parmentier, C; Schlumberger, M | 1 |
3 other study(ies) available for idarubicin and Primary Myelofibrosis
| Article | Year |
|---|---|
Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
Topics: Acute Disease; Adenocarcinoma; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Colorectal Neoplasms; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Second Primary; Organoplatinum Compounds; Oxaliplatin; Pancytopenia; Primary Myelofibrosis; Remission Induction; Tretinoin | 2016 |
Acute promyelocytic leukemia in a patient with idiopathic myelofibrosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hydroxyurea; Idarubicin; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Mitoxantrone; Primary Myelofibrosis; Remission Induction | 1999 |
Serum procollagen-III-peptide as a marker for primary myelofibrosis: effect of anthracyclin.
Topics: Daunorubicin; Humans; Idarubicin; Male; Middle Aged; Peptide Fragments; Primary Myelofibrosis; Procollagen | 1987 |